Armistice Capital, LLC Bicycle Therapeutics PLC Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Armistice Capital, LLC holds 2,196,000 shares of BCYC stock, worth $25.6 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
2,196,000
Previous 1,956,000
12.27%
Holding current value
$25.6 Million
Previous $44.4 Million
30.7%
% of portfolio
0.43%
Previous 0.74%
Shares
8 transactions
Others Institutions Holding BCYC
# of Institutions
104Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$127 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$53.1 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$40.3 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$30.4 Million0.17% of portfolio
-
Siren, L.L.C. New York, NY1.84MShares$21.4 Million1.14% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $346M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...